Oral bisphosphonates: Early endosseous dental implant success and crestal bone changes. a retrospective study

International Journal of Oral and Maxillofacial Implants

Volumn 27, Issue 5, 2012, Pages 1216-1222

  Memon, Sayma ^a   Weltman, Robin L ^b   Katancik, James A ^c  

^a The University of Texas School of Dentistry ^*  (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Bisphosphonates; Dental implants

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; DRUG DERIVATIVE; ETIDRONIC ACID; IBANDRONIC ACID; RISEDRONIC ACID;

AGED; ALVEOLAR BONE LOSS; ANALYSIS OF VARIANCE; ARTICLE; CASE CONTROL STUDY; DRUG EFFECT; FEMALE; HUMAN; JAW; METHODOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RADIOGRAPHY; RETROSPECTIVE STUDY; TOOTH IMPLANT; TOOTH IMPLANTATION; VERY ELDERLY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ALENDRONATE; ALVEOLAR BONE LOSS; ALVEOLAR PROCESS; ANALYSIS OF VARIANCE; BONE DENSITY CONSERVATION AGENTS; CASE-CONTROL STUDIES; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DIPHOSPHONATES; ETIDRONIC ACID; FEMALE; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84875226483     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. National Osteoporosis Foundation. Osteoporosis Clinical Updates. June 2008, 1-12. Available at http://www.nof.org/professionals/ clinicalupdatesintroduction. Accessed 23 August 2012.
2. SDI Vector One: National Data Extracted 11-2010. Sept 2007-Aug 2010 File: VONA_2010-2009_Actonel_TRx_by_market_12-06-10(1). xls. Available at www.fda.gov/downloads/AdvisoryCommittees/…/ UCM255031.pdf. Accessed 24 Aug 2012.
3. Green J. Bisphosphonates: Preclinical review. J Oncologist 2004; 9: 3-13.
4. Fleisch H, Russell R, Straumann F. Effect of pyrophosphate on hydroxyapatite and its implications on calcium hemostasis. Nature 1966; 212: 901-903.
5. Benford H, Frith J, Auriola S, Monkkonen J, Rogers M. Farnesol and geranylgerniol prevent activation of caspases by aminobisphosphonates:Biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs. Mol Pharmacol 1999; 56: 131-140.
6. Frith J, Monkkonen J, Blackburn G, Russell R, Rogers M. Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res 1997; 12: 1358-1367.
7. Jones D, Nakashima T, Sanchez O, et al. Regulation of cancer cell migration and bone metastasis by RANKL. Nature 2006; 440: 692-696.
8. Sezer O, Heider U, Zavarski I, Kuhne C, Hofbauer L. Rank ligand and osteoprotegerin in myeloma bone disease. Blood 2003; 101: 2094-2098.
9. Woo S, Hellstein J, Kalmar J. Bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006; 144: 753-756.
10. Marx R, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005; 63: 1567-1575.
11. American Association of Oral and Maxillofacial Surgeons. Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws-2009 Update, 1-23. http://www.aaoms.org/docs/position_papers/ osteonecrosis.pdf. Accessed 23 August 2012.
12. Bamias A, Kastritis E, Bamia C, et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors. J Clin Oncol 2005; 23: 8580-8587.
13. Dimopoulos M, Kastritis E, Anagnostopoulos A, et al. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates:Evidence of increased risk after treatment with zolendronic acid. Haematologica 2006; 91: 968-971.
14. Dimopoulos M, Kastritis E, Moulopoulos L, et al. The incidence of osteonecrosis of the jaw (ONJ) in patients with multiple myeloma who receive biphosphonates depends on the type of biphosphonate [abstract 637]. Blood 2005; 106: 189a.
15. Tosi P, Zamagni E, Cangini D, et al. Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone. Blood 2006; 108: 3951-3952.
16. Cafro A, Barbarano L, Andriani A, et al. Osteonecrosis of the jaw associated with chronic bisphosphonates therapy: An Italian experience [abstract 5152]. Blood 2005; 106: 371b.
17. Zavras A, Zhu S. Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: Is it osteonecrosis? J Oral Maxillofac Surg 2006; 64: 917-923.
18. Hoff A, Toth B, Altundag K, et al. Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy. J Bone Miner Res 2005; 20: S55.
19. Ruggiero S, Mehrotra B, Rosenberg T, Engroff S. Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg 2004; 62: 527-534.
20. Purcell P, Boyd I. Bisphosphonates and osteonecrosis of the jaws. Med J Aust 2005; 182: 417-418.
21. Edwards B, Hellstein J, Jacobsen P, Kaltman S, Mariotti A, Migliorati C. Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy. J Am Dent Assoc 2008; 139: 1674-1677.
22. Jeffcoat M. Safety of oral bisphosphonates: Controlled studies on alveolar bone. Int J Oral Maxillofac Implants 2006; 21: 349-353.
23. Fugazzoto P, Scott W, Jaffin R, Kumar A. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: Postoperative healing, early follow-up, and the incidence of complications in two private practices. J Periodontol 2007; 78: 1664-1669.
24. Grant B, Amenedo C, Freeman K, Kraut R. Outcomes of placing dental implants in patients taking oral bisphosphonates: A review of 115 cases. J Oral Maxillofac Surg 2008; 66: 223-230.
25. Bell B, Bell R. Oral bisphosphonates and dental implants: A retrospective study. J Oral Maxillofac Surg 2008; 665: 1022-1024.
26. Kasai T, Pogrel M, Hossaini M. The prognosis for dental implants placed in patients taking oral bisphosphonates. J Calif Dent Assoc 2009; 37: 39-42.
27. Albrektsson T, Zarb G, Worthington P, Eriksson A. The long-term efficacy of currently used dental implants: A review and proposed criteria of success. J Oral Maxillofac Implants 1986; 1: 11-25.